DR Tablet, Sprinkle Fasting Study [Design Issues]

posted by drgunasakaran1  – 2014-08-07 20:39 (4339 d 22:00 ago) – Posting: # 13352
Views: 5,866

Dear Mr MGR,

❝ Can we do a sprinkle study for a DR tablet, USFDA submission? If so could you please provide the guidelines link or so?


Yes. You need to conduct Sprinkle fasting study with Doxycycline Delayed release tablets for FDA submission.

The RLD for Doxycycline Delayed release tablets is Doryx of Mayne Pharma. As per the prescribing information of Doryx, DORYX (Doxycycline Hyclate Delayed-Release Tablets, USP), for oral administration, contain specially coated pellets of doxycycline hyclate.
DORYX Tablets may also be administered by carefully breaking up the tablet and sprinkling the tablet contents (delayed-release pellets) on a spoonful of applesauce.
Hence, you need to break the tablets and sprinkle the tablet contents (delayed-release pellets) on a spoonful of applesauce in the Sprinkle Fasting BE study.

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
134 visitors (0 registered, 134 guests [including 27 identified bots]).
Forum time: 18:40 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5